Pathogenic variants in JAG1 are identified in ~94% of individuals with Alagille syndrome. The majority of these are protein-truncating variants, full or partial gene deletions and the disease pathomechanism is haploinsufficiency. About 15% of patients have missense variants and splice variants are also identified in a subset of patients. Most variants are identified by sequencing and deletion/duplication-based testing.
JAG1